Emily Powell's Rare Disease Story

Conversations on Cancer – Perspectives on Cancer Care Decision-Making Among Older Adults

FDA Direct: Removing Black Box Warnings for HRT (Part 2/2)

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S06 - (PV): Regulatory Updates

Medical Device Quality Management System Regulation Risk Management

FDA Direct: Catching Up on Agency Reforms

Kerry Jo Lee's Work on Rare Diseases

Initiating the Removal of the “Black Box Warning” on Hormone Replacement Therapy

GCP & Pharmacovigilance Compliance Symposium | D3S03-1 - (BE): Clinical Study Conduct

FDA Direct: Removing Black Box Warnings for HRT (Part 1/2)

FDA Expert Panel on Testosterone Replacement Therapy for Men

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S07 – Q&A Discussion Panel

Public Meeting: Reauthorization of the Biosimilar User Fee Act

Medical Device Quality Management System Regulation Design and Development

Braulio Hernandez - Hodgkin’s Lymphoma

FDA Direct: FDA Awards Six National Priority Vouchers

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S05 - (PV): Future of...

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S03-2 – Q&A Discussion Panel

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S08 – Symposium Wrap-up and...

Susan Chittooran's Work on Rare Diseases

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S04 - (PV): International...